Supplement and peptide marketing that stays on the right side of the FTC

Supplement marketing has two failure modes. The first is a product page written by the formulator: ingredients, dosages, mechanisms, no reason to buy. The second is a page written by a copywriter with no formulator: claims that get the brand a warning letter. The job is the narrow path between them: understandable, persuasive and substantiated.

The product page, rebuilt

Outcome first: what changes for the person and how soon. Then who it's for. Then the ingredients, each with one plain-English line on why it's there. Then the evidence, linked. Then the routine: when to take it, with what, for how long. Then reviews and creator videos. Then price and the button. Most pages have all of these in the wrong order or missing the first one.

Claims

Structure/function claims ("supports healthy sleep") are allowed with the standard disclaimer; disease claims ("treats insomnia") are not. Every efficacy claim needs competent and reliable scientific evidence behind it. Testimonials must reflect typical results or say they don't. Peptides add another layer: many are not approved for human use as supplements and marketing them as such is a regulatory problem, not a copy problem. We write to the line, not over it.

Creator campaigns for supplements

Supplements are the ideal UGC category: a real person, a real routine, a real "here's what I noticed after three weeks." Brief creators on the claims they can and can't make. Give them the outcome sentence and let them say it their way. Test twelve videos, run the three that convert as ads, and feed the winning language back into the product page.

Retention is the margin

A supplement business is a subscription business whether it admits it or not. The second order is where the profit is. Post-purchase education (how to take it, what to expect by week), a check-in at day 20, and a subscribe offer that's genuinely better than one-off pricing do more for the P&L than another ad.